{"id":25,"date":"2026-06-08T15:19:17","date_gmt":"2026-06-08T13:19:17","guid":{"rendered":"https:\/\/alfakjn.com\/?page_id=25"},"modified":"2026-08-04T10:03:36","modified_gmt":"2026-08-04T08:03:36","slug":"urology-and-gynaecology","status":"publish","type":"page","link":"https:\/\/alfakjn.com\/en\/urologia-e-ginecologia\/","title":{"rendered":"Urology and Gynaecology"},"content":{"rendered":"
\n \n \n \n\t\n\n
<\/div>\n\n\n

\nUrology and Gynaecology\n<\/h1>
\n \n \n\t\n\n\n\n

\nRecurring conditions, growing specialist demand, and a market that is still insufficiently differentiated.\n<\/h2>
\n

Recurrent cystitis and chronic pelvic pain are high-prevalence conditions with a significant impact on patients' quality of life and a pattern of medical consultation that is often fragmented between urologists, gynaecologists and general practitioners. From a distributor's perspective, this is a segment with continuous demand and little differentiation in the available offering.<\/p>\n

The urology and gynaecology area represents an expanding speciality for Alfakjn, with products already on the market and a developing pipeline that is progressively broadening the coverage of the therapeutic area.<\/p>\n<\/div>\n<\/div><\/div>\n<\/section>

\n \n \n\t\n\n\n\n

\nControcyst: clear positioning in a complex segment\n<\/h2>
\n
\n \"Alfakjn\n<\/div>\n
\n

Controcyst<\/h3>\n \n

Medical device for the management of painful symptoms associated with forms of chronic urothelial inflammation and for the management of recurrent non-bacterial cystitis.<\/p>

Controcyst is indicated for painful bladder and pelvic syndrome, including that induced by radiotherapy or chemotherapy.<\/p>

For the distributor<\/strong>: product with precise indication and identified reference professionals (urologist, gynaecologist, uro-gynaecology), with the possibility of building a recognisable presence in a high-loyalty specialist channel.<\/p><\/div>\n \n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n\n \n View card<\/span>\n\n \n \n <\/a>\n\n \n\n <\/div>\n\n<\/div>

\n
\n \"Alfakjn\n<\/div>\n
\n

Controcyst<\/h3>\n \n

Medical device for the management of painful symptoms associated with forms of chronic urothelial inflammation and for the management of recurrent non-bacterial cystitis.<\/p>

Controcyst is indicated for painful bladder and pelvic syndrome, including that induced by radiotherapy or chemotherapy.<\/p>

For the distributor<\/strong>: product with precise indication and identified reference professionals (urologist, gynaecologist, uro-gynaecology), with the possibility of building a recognisable presence in a high-loyalty specialist channel.<\/p><\/div>\n \n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n\n \n View card<\/span>\n\n \n \n <\/a>\n\n \n\n <\/div>\n\n<\/div>

\nCHANNEL POSITIONING\n<\/h3>
\n

Controcyst lends itself to ongoing treatment pathways, which makes the product particularly suitable for distributors working with outpatient facilities, specialist clinics and hospital urology or gynaecology departments.<\/p>\n

The available technical documentation supports both positioning towards the prescribing professional and inclusion in structured clinical protocols.<\/p>\n<\/div><\/div>\n<\/section>

\n \n \n\t\n\n\n\n
\n
\n \"Alfakjn\n<\/div>\n
\n

Corakjn G-Restore <\/h3>\n \n

Recurrent cystitis and alterations of the genital flora remain one of the most frequent \u2014 and least resolved \u2014 issues in the uro-gynaecological field: the repeated use of antibiotic therapy does not eliminate the tendency to relapse, and often worsens the imbalance. <\/p>

Corakjn G-Restore intervenes with a unisex medical device in Thermogel technology, which turns from a spray into a gel upon contact with the mucosa: D-mannose, sodium hyaluronate, lactoferrin and tyndallised lactobacilli work together to hinder bacterial adhesion and promote the restoration of microbial balance, in the post-antibiotic phase, after pelvic radiotherapy or in the management of recurrences.<\/p>

Position Controcyst alongside the Alfakjn uro-gynaecological portfolio, targeting the couple to open up the conversation beyond the single acute episode.<\/p><\/div>\n \n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n\n \n View card<\/span>\n\n \n \n <\/a>\n\n \n\n <\/div>\n\n<\/div>

\n
\n \"Alfakjn\n<\/div>\n
\n

Corakjn G-Restore <\/h3>\n \n

Recurrent cystitis and alterations of the genital flora remain one of the most frequent \u2014 and least resolved \u2014 issues in the uro-gynaecological field: the repeated use of antibiotic therapy does not eliminate the tendency to relapse, and often worsens the imbalance. <\/p>

Corakjn G-Restore intervenes with a unisex medical device in Thermogel technology, which turns from a spray into a gel upon contact with the mucosa: D-mannose, sodium hyaluronate, lactoferrin and tyndallised lactobacilli work together to hinder bacterial adhesion and promote the restoration of microbial balance, in the post-antibiotic phase, after pelvic radiotherapy or in the management of recurrences.<\/p>

Position Controcyst alongside the Alfakjn uro-gynaecological portfolio, targeting the couple to open up the conversation beyond the single acute episode.<\/p><\/div>\n \n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n\n \n View card<\/span>\n\n \n \n <\/a>\n\n \n\n <\/div>\n\n<\/div>

\n \n \n\t\n\n\n\n

\nAn expanding area\n<\/h2>
\n

The name 'Urology and Gynaecology' reflects a broader vision of the area compared to the current product. Alfakjn is developing the pipeline for this therapeutic area, with the aim of offering the distributor a more comprehensive coverage in the medium term.<\/p>\n

Partners entering the area today build a privileged relationship with the reference channels, positioning themselves ahead of the portfolio expansion.<\/strong><\/p>\n<\/div>\n<\/div><\/div>\n<\/section>

\n \n \n\t\n\n\n\n
\n \n \n\t\n\n\n\n

\nWhat does the partnership include for this area\n<\/h2>
\n

For its partners in the urology and gynaecology area, Alfakjn provides:<\/p>\n